Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DM

23 Feb 2012

Abstract excerpt

Sir, Clinically amyopathic DM (C-ADM) is characterized by typical skin lesions with amyopathy or hypomyopathy and was recently reported to be complicated by rapidly progressive interstitial lung disease (RP-ILD), especially in those patients who express the anti-C-ADM-140 antibody [1]. RP-ILD with a fatal outcome is commonly associated with hyperferritinaemia [2–4]. However, it has not been clarified as yet why...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammatory Myopathies and Dermatomyositis
Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Share to Neurogenetic and Muscular Disorders Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22361226
DOI: 10.1093/rheumatology/kes012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DMPMID 22361226Read ↗

Anti-MDA5 (melanoma differentiation-associated gene 5) antibody and dermatomyositis with rapidly progressive interstitial pneumoniaSemantic proximity Read ↗

Two cases with autoantibodies to small ubiquitin‐like modifier activating enzyme: A potential unique subset of dermatomyositis‐associated interstitial lung diseaseSemantic proximity Read ↗

Using the serum LDH level as a biomarker for amyopathic dermatomyositis with interstitial lung disease: A retrospective study of 158 patients with nonspecific interstitial pneumonia or organizing pneumoniaSemantic proximity Read ↗

Anti-SAE Autoantibody-Positive Japanese Patient with Juvenile Dermatomyositis complicated with Interstitial Lung Disease - A Case ReportSemantic proximity Read ↗

Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis.Semantic proximity Read ↗

Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment.Semantic proximity Read ↗

Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: A case report and literature reviewSemantic proximity Read ↗

Coexistence of anti-MDA5 and anti-PL-7 in a patient with dermatomyositis: a case reportSemantic proximity Read ↗

AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells.Semantic proximity Read ↗

Evaluating Value of Lactic Dehydrogenase in Anti-MDA5-positive Dermatomyositis Associated with Interstitial Lung DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.